Advertisement

Topics

Latest Biological Patent NewsRSS

12:28 EDT 22nd June 2017 | BioPortfolio

Complex Partial SeizureGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Updated: 30052017] Prices from USD $1700

DelveInsight's Report, Complex Partial SeizureGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Complex Partial Seizure Report is to understand the market and pipeline status of the drugs around the Complex Partial...

Dental PainAPI Insights, 2017 [Updated: 30052017] Prices from USD $1063

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.India and China produce a large percentage of a majority o...

Overactive BladderGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Updated: 30052017] Prices from USD $1700

DelveInsight's Report, Overactive BladderGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Overactive Bladder Report is to understand the market and pipeline status of the drugs around the Overactive Bladder to exp...

IntegrilinAPI Insights, 2017 [Updated: 30052017] Prices from USD $425

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.India and China produce a large percentage of a majority o...

HIV / AIDSGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Updated: 30052017] Prices from USD $1700

DelveInsight's Report, HIV / AIDSGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the HIV / AIDS Report is to understand the market and pipeline status of the drugs around the HIV / AIDS to explore the generic develop...

Perennial Allergic RhinitisGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Updated: 30052017] Prices from USD $1700

DelveInsight's Report, Perennial Allergic RhinitisGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Perennial Allergic Rhinitis Report is to understand the market and pipeline status of the drugs around the Perenni...

DysuriaGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Updated: 30052017] Prices from USD $1700

DelveInsight's Report, DysuriaGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Dysuria Report is to understand the market and pipeline status of the drugs around the Dysuria to explore the generic development oppo...

ObesityAPI Insights, 2017 [Updated: 30052017] Prices from USD $1063

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.India and China produce a large percentage of a majority o...

Teva loses $235m patent trial to GSK

A US court dismissed Teva's claim that GlaxoSmithKline's patent for the Coreg drug was invalid.

KaletraAPI Insights, 2017 [Updated: 30052017] Prices from USD $425

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.India and China produce a large percentage of a majority o...

Biliary Tract InfectionGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Updated: 30052017] Prices from USD $1700

DelveInsight's Report, Biliary Tract InfectionGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Biliary Tract Infection Report is to understand the market and pipeline status of the drugs around the Biliary Tract I...

Herpes Labialis Oral HerpesAPI Insights, 2017 [Updated: 30052017] Prices from USD $1063

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.India and China produce a large percentage of a majority o...

Berylliosis Chronic Beryllium DiseaseAPI Insights, 2017 [Updated: 30052017] Prices from USD $1063

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.India and China produce a large percentage of a majority o...

Alzheimer's DiseaseGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Updated: 30052017] Prices from USD $1700

DelveInsight's Report, Alzheimer's DiseaseGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Alzheimer's Disease Report is to understand the market and pipeline status of the drugs around the Alzheimer's Disease to ...

Singulair PaediatricAPI Insights, 2017 [Updated: 30052017] Prices from USD $425

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.India and China produce a large percentage of a majority o...

IndigestionAPI Insights, 2017 [Updated: 30052017] Prices from USD $1063

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.India and China produce a large percentage of a majority o...

MiMedx Is Issued Four Additional U.S. Patents For Placental Tissue Grafts

KENNESAW, Ga., Feb. 11, 2013 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its receipt of four new issued patents related to tissue grafts derived from the placenta. The U.S. Patent Office has issued to MiMedx U.S. Pa...

Proair HFAAPI Insights, 2017 [Updated: 30052017] Prices from USD $425

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.India and China produce a large percentage of a majority o...

Vulvovaginal CandidiasisGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Updated: 30052017] Prices from USD $1700

DelveInsight's Report, Vulvovaginal CandidiasisGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Vulvovaginal Candidiasis Report is to understand the market and pipeline status of the drugs around the Vulvovaginal ...

BronchospasmAPI Insights, 2017 [Updated: 30052017] Prices from USD $1063

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.India and China produce a large percentage of a majority o...

Anterior UveitisGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Updated: 30052017] Prices from USD $1700

DelveInsight's Report, Anterior UveitisGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Anterior Uveitis Report is to understand the market and pipeline status of the drugs around the Anterior Uveitis to explore t...

UloricAPI Insights, 2017 [Updated: 30052017] Prices from USD $425

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.India and China produce a large percentage of a majority o...

OsteoporosisAPI Insights, 2017 [Updated: 30052017] Prices from USD $1063

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.India and China produce a large percentage of a majority o...

EmpyemaGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Updated: 30052017] Prices from USD $1700

DelveInsight's Report, EmpyemaGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Empyema Report is to understand the market and pipeline status of the drugs around the Empyema to explore the generic development oppo...

Acute BronchitisAPI Insights, 2017 [Updated: 30052017] Prices from USD $1063

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.India and China produce a large percentage of a majority o...

Quick Search
Advertisement
 

review and buy Biological Patent market research data and corporate reports here